Literature DB >> 21546646

Critical issues associated with drug-drug interactions: highlights of a multistakeholder conference.

Lisa E Hines1, John E Murphy, Amy J Grizzle, Daniel C Malone.   

Abstract

Mesh：

Year:  2011        PMID： 21546646     DOI： 10.2146/ajhp100440

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  8 in total

1.  Identification and evaluation of drug-supplement interactions in Hungarian hospital patients.

Authors:  Anna Végh; Erzsébet Lankó; András Fittler; Róbert György Vida; Ildikó Miseta; Gábor Takács; Lajos Botz
Journal:  Int J Clin Pharm       Date:  2014-02-23

2.  Drug Interactions in Space: a Cause for Concern?

Authors:  Erez Berman; Sara Eyal
Journal:  Pharm Res       Date:  2019-05-31       Impact factor: 4.200

3.  Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis.

Authors:  Katsiaryna Bykov; Sebastian Schneeweiss; Robert J Glynn; Murray A Mittleman; David W Bates; Joshua J Gagne
Journal:  Drug Saf       Date:  2017-10       Impact factor: 5.606

4.  Towards a foundational representation of potential drug-drug interaction knowledge.

Authors:  Mathias Brochhausen; Jodi Schneider; Daniel Malone; Philip E Empey; William R Hogan; Richard D Boyce
Journal:  CEUR Workshop Proc       Date:  2014-10

Review 5.  Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis.

Authors:  Wu Yi Zheng; L C Richardson; L Li; R O Day; J I Westbrook; M T Baysari
Journal:  Eur J Clin Pharmacol       Date:  2017-10-23       Impact factor: 2.953

6.  Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness.

Authors:  Richard D Boyce; John R Horn; Oktie Hassanzadeh; Anita de Waard; Jodi Schneider; Joanne S Luciano; Majid Rastegar-Mojarad; Maria Liakata
Journal:  J Biomed Semantics       Date:  2013-01-26

7.  Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.

Authors:  Tâmara Natasha Gonzaga de Andrade Santos; Givalda Mendonça da Cruz Macieira; Bárbara Manuella Cardoso Sodré Alves; Thelma Onozato; Geovanna Cunha Cardoso; Mônica Thaís Ferreira Nascimento; Paulo Ricardo Saquete Martins-Filho; Divaldo Pereira de Lyra; Alfredo Dias de Oliveira Filho
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

8.  Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.

Authors:  Anna Somogyi-Végh; Zsófia Ludányi; Ábel Erdős; Lajos Botz
Journal:  BMC Pharmacol Toxicol       Date:  2019-05-31       Impact factor: 2.483
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.